pulseTV

VIDEO: Demonstration of Shimadzu's Trinias Interventional X-ray System

Angiography | November 22, 2017

Shimadzu demonstrated its Trinias Interventional X-ray System at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) conference. The system offers several features to enable improved patient access and procedural guidance at a lower radiation dose than previous generation angiography systems. For more information visit www.shimadzu.com/med/products/angio.

Cath Lab

/videos/video-demonstration-shimadzus-trinias-interventional-x-ray-system
Angiography | November 22, 2017
VIDEO: Demonstration of Shimadzu's Trinias Interventional X-ray System

Shimadzu demonstrated its Trinias Interventional X-ray System at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) conference. The system offers several features to enable improved patient access and procedural guidance at a lower radiation dose than previous generation angiography systems. For more information visit www.shimadzu.com/med/products/angio.

VIDEO: Demonstration of Shimadzu's Trinias Interventional X-ray System
/videos/video-new-frontiers-radial-access
Radial Access | November 22, 2017
VIDEO: New Frontiers in Radial Access

Mladen I. Vidovich, M.D., FACC, FSCAI, chief, section of cardiology, Jesse Brown VA Medical Center, Chicago, and associate professor of medicine at the University of Illinois at Chicago, discusses some of the current techniques and issues involved with radial artery access. DAIC spoke to him at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) conference. Read articles he authored, including “Radiation Exposure Related to Transradial Access,” “5 Ways to Reduce Door to Balloon Time,” and “Vascular Closure Devices Aid Closure of Large Access Sites.”

 

VIDEO: New Frontiers in Radial Access
/videos/video-applications-cardiology-3-d-printing-and-computer-aided-design
3-D Printing | November 17, 2017
VIDEO: Applications in Cardiology for 3-D Printing and Computer Aided Design

Dee Dee Wang, M.D., Director, Structural Heart Imaging at Henry Ford Hospital, Detroit, explains how her center uses 3-D printing and computer aided design (CAD) software to improve patient outcomes. She spoke to DAIC at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting. Read the articles “The Use of 3-D Printing in Cardiology” and “Henry Ford Hospital Study Shows 3-D Imaging Improves Fixing Broken Hearts.”  

VIDEO: Applications in Cardiology for 3-D Printing and Computer Aided Design
/videos/video-use-tryton-dedicated-bifurcation-stent
Stents Bifurcation | November 15, 2017
VIDEO: Use of the Tryton Dedicated Bifurcation Stent

Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at Morristown Medical Center, part of Atlantic Health System, explains his experience with the Tryton Side Branch stent in both clinical practice and as an investigator in the Tryton Pivotal IDE Trial. Read the article “Data Published for Pivotal Trial for Tryton Side Branch Stent,” and about the regulatory clearance “FDA Clears First Dedicated Coronary Bifurcation Stent.”

VIDEO: Use of the Tryton Dedicated Bifurcation Stent
/videos/video-editors-choice-most-innovative-new-technologies-tct-2017
TCT | November 15, 2017
VIDEO: Editor's Choice of the Most Innovative New Technologies at TCT 2017

DAIC Editor Dave Fornell shows some of the innovations displayed on the expo floor at the 2017 Transcatheter Cardiovascular Therapeutics (TCT). Hear what Cardiovascular Research Foundation (CRF) President and CEO Juan Granada, M.D., feels are the hottest technologies to watch. 

VIDEO: Editor's Choice of the Most Innovative New Technologies at TCT 2017
/videos/video-angiography-image-based-ffr-may-eliminate-need-pressure-wires
FFR Technologies | November 15, 2017
VIDEO: Angiography Image-based FFR May Eliminate Need for Pressure Wires

A discussion with William Fearon, M.D. director of interventional cardiology, Stanford University Medical Center, about the FAST-FFR Trial he is heading. It is comparing wire-based fractional flow reserve (FFR) to angiography image-derived FFR. The technology may open the door to wider use of FFR by eliminating costs, disruption and extra time in the cath lab workflow, the use of pressure wires and eliminate the need for adenosine. Watch a VIDEO on the early adoption of FFR-CT technology to assess chest pain patients

VIDEO: Angiography Image-based FFR May Eliminate Need for Pressure Wires
/videos/video-clinical-outcomes-lotus-tavr-valve
Heart Valve Technology | November 15, 2017
VIDEO: Clinical Outcomes With the Lotus TAVR Valve

Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, is the principal investigator for the Lotus valve’s U.S. pivotal trial. He explains what the clinical data to date has been for this new transcatheter aortic valve replacement (TAVR) device, which will likely become the third available on the U.S. market. Read the article "Lotus TAVR System Shows Superior Efficacy to CoreValve in Global REPRISE III Trial."

 

VIDEO: Clinical Outcomes With the Lotus TAVR Valve
/videos/video-new-data-laa-occlusion-prevail-and-protect-trials
Left Atrial Appendage (LAA) Occluders | November 14, 2017
VIDEO: New Data on LAA Occlusion From the PREVAIL and PROTECT Trials

Vivek Reddy, M.D., director of cardiac arrhythmia services and professor of medicine, cardiology, Mount Sinai Hospital, N.Y., explains the latest Watchman left atrial appendage (LAA) occluder study data presented at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) conference. Watch the VIDEO “Post-FDA Approval Experience of LAA Occluders,” with David Holmes, M.D. Watch a VIDEO interview with Reddy at Heart Rhythm Society (HRS) 2017 on leadless pacing technologies

VIDEO: New Data on LAA Occlusion From the PREVAIL and PROTECT Trials
/videos/video-converting-bundled-payments-pci
Business | November 09, 2017
VIDEO: Converting to Bundled Payments for PCI

A discussion with Peter L. Duffy, M.D., MMM, FACC, FSCAI CPE, interventional cardiologist and former director of quality for the cardiovascular service line at FirstHealth of the Carolinas Reid Heart Institute, at Moore Regional Hospital in Pinehurst, N.C. Read the article with Duffy “Interventional Cardiologist Redefines Value for Everyday Medical Practice.” Read the article “Preparing Hospitals for Mandatory Medicare Cardiac Bundled Payments.”

VIDEO: Converting to Bundled Payments for PCI
/videos/video-overview-national-cardiogenic-shock-initiative
Hemodynamic Support Devices | November 09, 2017
VIDEO: Overview of the National Cardiogenic Shock Initiative

A discussion with William W. O’Neill, M.D., medical director, Center for Structural Heart Disease, Henry Ford Hospital, Detroit, about the creation of a national initiative to start percutaneous hemodynamic support first before beginning revascularization. O’Neill started the Detroit Cardiogenic Shock Initiative with several hospitals in 2016 and saw a 50 percent drop in mortality. Read the article “Detroit Cardiogenic Shock Initiative Goes National at TCT 2017.” Watch the VIDEO “Cardiogenic Shock Supported With Impella Shows Good Outcomes.”

VIDEO: Overview of the National Cardiogenic Shock Initiative
/videos/video-how-transcatheter-pfo-closure-can-reduce-cryptogenic-stroke
Structural Heart Occluders | November 08, 2017
VIDEO: How Transcatheter PFO Closure Can Reduce Cryptogenic Stroke

John Rhodes, M.D., co-director of the adult congenital heart program, Medical University of South Carolina, is the principal investigator for the REDUCE Trial, the FDA pivotal study using the Cardioform for PFO closure to prevent cryptogenic stroke. He discusses some of the data showing benefit for patients and debate around all the trials for PFO closure. Read about the results of the REDUCE trial in the article “PFO Closure Shows Positive Results from REDUCE Clinical Study.” Read about the approval of the first PFO closure device in 2016.

VIDEO: How Transcatheter PFO Closure Can Reduce Cryptogenic Stroke
/videos/video-cath-lab-future-cardiovascular-technologies-watch
Cath Lab | November 08, 2017
VIDEO: Cath Lab of the Future Cardiovascular Technologies to Watch

Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on what technologies he predicts will become main stream therapies in the coming years. DAIC spoke to him at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) conference. Read the article “The Future of Cardiology: 17 Technologies to Watch.” Watch other VIDEOS with Granada, “Transcatheter Mitral Valve Therapies in Development.” “The Evolution of TAVR Technology,” and “Bioresorbable Stent Failure Modes, Technique, Patient Selection and Future Development.”

VIDEO: Cath Lab of the Future Cardiovascular Technologies to Watch
/videos/video-tavr-asymptomatic-severe-aortic-stenosis
Heart Valve Technology | November 08, 2017
VIDEO: TAVR For Asymptomatic Severe Aortic Stenosis

Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at Morristown Medical Center, part of Atlantic Health System, explains the EARLY TAVR trial evaluating the use of transcatheter aortic valve replacement compared to surveilLance for patients With asymptomatic severe aortic stenosis. Genereux is the principal investigator for the trial. Read more about the EARLY TAVR trial

VIDEO: TAVR For Asymptomatic Severe Aortic Stenosis
/videos/video-maveric-6-month-outcomes-arto-mitral-valve-reshaping-system
Heart Valve Technology | November 08, 2017
VIDEO: MAVERIC 6-month Outcomes for the Arto Mitral Valve Reshaping System

Stephen Worthley, MB, BS, Ph.D., director of cardiac catheterization, University of Adelaide, Australia, presents the MAVERIC Trial six-month outcomes using the Arto System at a press conferences at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting. Read more about the trial in the article “Arto System Shows Promise as Less-Invasive Therapy for Heart Failure Patients.” Watch a VIDEO interview with Worthley on “Drug-Filled Stents as an Alternative to Polymer Drug Carriers.” 

VIDEO: MAVERIC 6-month Outcomes for the Arto Mitral Valve Reshaping System
/videos/video-what-went-wrong-absorb-stent
Stents Bioresorbable | November 07, 2017
VIDEO: What Went Wrong With the Absorb Stent?

A discussion with Ajay Kirtane, M.D., SM, director of the cardiac catheterization laboratories at New York-Presbyterian Hospital/Columbia University Medical Center, on the ABSORB III 3-year outcomes and other Absorb data presented at TCT 2017. He explains more on the poor outcomes for the bioresorbable stent compared to the Xience metallic stent and procedural issues based on operator technique and experience. Read the article “Abbott Will End Sales of Absorb Bioresorbable Stent.” Watch the VIDEO “Bioresorbable Stent Comparable to Xience at Two Years, With Concerns,” with Stephen Ellis, M.D. Watch the VIDEO “Poor Outcomes for Bioresorbable Stents in Small Coronary Arteries,” with Gregg Stone, M.D.

VIDEO: What Went Wrong With the Absorb Stent?
/videos/video-update-mitral-valve-repair-and-replacement-technologies
Heart Valve Technology | November 07, 2017
VIDEO: Update of Mitral Valve Repair and Replacement Technologies

Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, explains the current state of transcatheter mitral valve technologies in development and in trials. He is involved in some of these trials and was the principal investigator for the pivotal MitraClip trial. Watch the VIDEO “Transcatheter Mitral Valve Technology, Anatomical Challenges” with Juan Granada, M.D.. Read the articles “Advances and Future Directions for Transcatheter Valves,” and “Transcatheter Mitral Valve Replacement Devices in Development.”

VIDEO: Update of Mitral Valve Repair and Replacement Technologies
/videos/video-transcaval-access-tavr-procedures
Heart Valve Technology | October 27, 2017
VIDEO: Transcaval Access in TAVR Procedures

Adam Greenbaum, M.D., co-director of the structural heart program at Henry Ford Health System in Detroit, discusses the innovative approach to transcatheter aortic valve replacement (TAVR) being pioneered at HFHS. Read "Henry Ford Hospital Cardiologist Receives National Award for Innovating Transcaval Heart Procedure."

VIDEO: Transcaval Access in TAVR Procedures
/videos/video-conscious-sedation-tavr-procedures
Heart Valve Technology | October 23, 2017
VIDEO: Conscious Sedation for TAVR Procedures

A discussion with Mario Goessl, M.D., Ph.D., director of research and education at the Minneapolis Heart Institute. He presented research at ACC.17 on the cost savings and reduced patient recovery time achieved by using conscious sedation during transcatheter aortic valve repair (TAVR) procedures. Read the articles "Conscious Sedation TAVR Reduced Length-of-Stay and Hospital Costs," and "Moderate Sedation Shows Promise for TAVR Patients."

VIDEO: Conscious Sedation for TAVR Procedures
/videos/video-treating-chronic-total-occlusions
Chronic Total Occlusion (CTO) | October 09, 2017
VIDEO: Treating Chronic Total Occlusions

Bill Lombardi, M.D., director of complex coronary artery interventions at the University of Washington, discusses the principles, training and technologies required for treating chronic total occlusions (CTOs) at ACC.17. Watch the VIDEO “New Technology to Treat Chronic Total Occlusions (CTOs)” with Farouc Jaffer, M.D., Ph.D., director of coronary interventions at Massachusetts General Hospital. Read the article “When to Consider Revascularization of Coronary Chronic Total Occlusions.”

VIDEO: Treating Chronic Total Occlusions
/videos/video-new-technology-treat-chronic-total-occlusions-ctos
Chronic Total Occlusion (CTO) | September 28, 2017
VIDEO: New Technology to Treat Chronic Total Occlusions (CTOs)

Farouc Jaffer, M.D., Ph.D., director of coronary interventions at Massachusetts General Hospital, discusses the newest advances and technologies for treating chronic total occlusions (CTOs) at ACC.17. Read the article "When to Consider Revascularization of Coronary Chronic Total Occlusions."

VIDEO: New Technology to Treat Chronic Total Occlusions (CTOs)
/videos/video-transcatheter-closure-holes-heart
Structural Heart Occluders | September 13, 2017
VIDEO: Transcatheter Closure of Holes in the Heart

Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Sidra Medical and Research Center in Doha, Qatar, discusses the latest technologies for ASD and PFO closure at ACC.17. Read the article “Closing Holes in the Heart.”
 

VIDEO: Transcatheter Closure of Holes in the Heart
/videos/video-mitral-and-tricuspid-valve-repair-technologies
Heart Valve Technology | August 30, 2017
VIDEO: Mitral and Tricuspid Valve Repair Technologies

Azeem Latib, M.D., MBBCh, FCP, interventional cardiologist at Columbus Hospital in Milan, Italy, discusses the latest innovations in mitral and tricuspid valve repair technologies at ACC.17. Read an article by Latib, “Transcatheter Annuloplasty For Repair Versus Replacement in Functional Mitral Regurgitation.” Watch the related VIDEO with Rebecca Hahn, M.D., "Transcatheter Tricuspid Valve Repair and Replacement Technologies."

 

VIDEO: Mitral and Tricuspid Valve Repair Technologies
/videos/video-how-implant-dialysis-access-graft-complex-patient
Peripheral Artery Disease (PAD) | July 25, 2017
VIDEO: How to Implant a Dialysis Access Graft in a Complex Patient

This video case study, provided by Gore Medical, is titled "Tackling Complex Cases in Dialysis Access," by John Ross, M.D., director, Dialysis Access Institute, The Regional Medical Center, Orangeburg, S.C. It demonstrates in a recorded case how to surgically implant a Gore Hybrid Vascular Graft. To view the entire series of complex peripheral disease cases, visit medicalmastery.goremedical.com.

VIDEO: How to Implant a Dialysis Access Graft in a Complex Patient
/videos/video-how-ekos-thrombolytic-technology-works-dissolve-clots
Venous Therapies | June 27, 2017
VIDEO: How the Ekos Thrombolytic Technology Works to Dissolve Clots

This video, provided by Ekos, demonstrates the EkoSonic endovascular System thrombolytic system to treat deep vein thrombosis (DVT), chronic deep vein thrombosis (Chronic DVT) and pulmonary embolism (PE). The Ekos system delivers catheter-directed fibrinolytics with the aid of high-frequency, low-energy ultrasound, which allows penetration of the drug deeper into the clot. Read the article “Acute Intermediate-Risk Pulmonary Embolism: A High-Stakes Conundrum.” Read the article “Aggressive Pulmonary Embolism Response and Evolving Technologies.” Read the article “Ultrasound-assisted Catheter-directed Thrombolysis Reduces Treatment Risks for Pulmonary Emboli.”

 

VIDEO: How the Ekos Thrombolytic Technology Works to Dissolve Clots
/videos/video-latest-advances-shimadzus-angiography-imaging-systems
Angiography | June 22, 2017
VIDEO: Latest Advances With Shimadzu's Angiography Imaging Systems

Shimadzu Medical Systems highlighted new features of its Trinias Interventional X-ray line at the America College of Cardiology (ACC) 2017. A key feature of Trinias, is the ability to image from fingertip to fingertip during a transradial approach, which makes for much shorter hospital stay with the patient up and moving almost immediately after the procedure. Features Like RSM-DSA, a type of motion correction subtraction, eliminating the artifacts from the patient motion during acquisition while STENTVIEW, is an enhanced visualization during stent placement in real-time. Shimadzu also highlighted its partnership with Raysafe and its real-time staff radiation dose monitoring solution. For more information: http://shimadzu.com/med/products/angio/index.html

VIDEO: Latest Advances With Shimadzu's Angiography Imaging Systems
/videos/video-incorporation-3-d-echo-peri-operative-practice
Cardiovascular Ultrasound | June 15, 2017
VIDEO: Incorporation of 3-D Echo Into Peri-operative Practice

Madhav Swaminathan, M.D., FASC, FAHA, clinical director of cardiothoracic anesthesiology, at Duke University Medical Center, discusses use of cardiac ultrasound in cardiac surgery and interventional structural heart procedures at the 2017 American Society of Echocardiography (ASE) annual meeting. Watch the related VIDEO "What is Required for Interventional Echo - Discussion With Rebecca Hahn," or read the article “Requirements for Interventional Echocardiographers.” 

VIDEO: Incorporation of 3-D Echo Into Peri-operative Practice
/videos/video-transcatheter-tricuspid-valve-repair-and-replacement-technologies
Heart Valve Technology | June 14, 2017
VIDEO: Transcatheter Tricuspid Valve Repair and Replacement Technologies

A discussion with Rebecca Hahn, M.D., FASE, director of interventional echocardiography and professor of medicine at Columbia University Medical Center / New York-Presbyterian Hospital, New York. She is the national principal investigator for the SCOUT I Trial for the Trialign Percutaneous Tricuspid Valve Annuloplasty System. For information on the development of transcatheter mitral valve  technologies read the article "Transcatheter Mitral Valve Replacement Devices in Development." Watch a video with Hahn explaining the requirements for creating an interventional echo program to support structural heart interventions.

VIDEO: Transcatheter Tricuspid Valve Repair and Replacement Technologies
/videos/video-how-start-electrophysiology-program
Business | June 06, 2017
VIDEO: How to Start an Electrophysiology Program

Andrea Natale, M.D., FACC, FHRS, FESC, executive medical director, Texas Cardiac Arrhythmia Institute at St. David's Medical Center, discusses how to build an electrophysiology (EP) program at the 2017 Heart Rhythm Society annual meeting. Read the article "Growing a Cardiac Rhythm Program in a Community Setting."
 

 

VIDEO: How to Start an Electrophysiology Program
/videos/video-demonstration-how-bridge-occlusion-balloon-seals-svc-tears
EP Lab | May 17, 2017
VIDEO: Demonstration of How the Bridge Occlusion Balloon Seals SVC Tears

This video, provided by Spectranetics, demonstrates how to deploy the Bridge Occlusion Balloon used to seal accidental tears in the superior vena cava (SVC) during EP device lead extraction procedures. A review of post-market release data shown it can bridge the patient to open surgical repair and significantly reduce the usual 50 percent mortality associated with this complication. Read the article about the late-breaking clinical trial presentation from Heart Rhythm 2017.

VIDEO: Demonstration of How the Bridge Occlusion Balloon Seals SVC Tears
/videos/video-shimadzus-trinias-interventional-x-ray-system
Angiography | May 03, 2017
VIDEO: Shimadzu's Trinias Interventional X-ray System

Tom Kloetzly, sales and marketing VP for Shimadzu Medical Systems USA, explains the evolution of Shimadzu Corporation since its founding 142 years ago. Kloetzly focuses on the Trinias Interventional X-ray line shown at RSNA 2016. Kloetzly states “A key feature of Trinias, is the ability to image from fingertip to fingertip during a transradial approach which makes for much shorter hospital stay with the patient up and moving almost immediately after the procedure. Features Like RSM-DSA, a type of motion correction subtraction, eliminates patient movement during acquisition while STENTVIEW, is an enhanced visualization during stent placement in real-time." For more information: www.shimadzu.com/med/products/angio/index.html.

 

VIDEO: Shimadzu's Trinias Interventional X-ray System
/videos/video-resolute-onyx-drug-eluting-stent-procedural-animation
Stents Drug Eluting | May 01, 2017
VIDEO: Resolute Onyx Drug-Eluting Stent Procedural Animation

This video, provided by Medtronic, demonstrates the Resolute Onyx coronary stent. It was cleared by the FDA and launched into the U.S. market May 1, 2017. The stent is designed for greater deliverability and conformability to the vessel wall. It uses a radiopaque inner core wire to enhance visibility for accurate placement. Read the article "FDA Approves Medtronic’s Resolute Onyx Drug-eluting Stent."
 

 

VIDEO: Resolute Onyx Drug-Eluting Stent Procedural Animation
/videos/video-cardiogenic-shock-supported-impella-shows-good-outcomes
Ventricular Assist Devices (VAD) | April 14, 2017
VIDEO: Cardiogenic Shock Supported With Impella Shows Good Outcomes

A discussion with William O'Neill, M.D., FACC, FSCAI, medical director of the Center for Structural Heart Disease at Henry Ford Hospital, Detroit. He presented a late-breaking study on the outcomes for 15,259 U.S. patients with acute MI in cardiogenic shock supported with the Impella percutenous ventricular assist device. Read more about the Detroit Cardiogenic Shock Initiative.

VIDEO: Cardiogenic Shock Supported With Impella Shows Good Outcomes
/videos/video-editors-choice-most-innovative-new-technology-acc17
ACC | April 03, 2017
VIDEO: Editor's Choice of Most Innovative New Technology at ACC.17

DAIC Editor Dave Fornell takes a tour of some of the interesting new technologies from the vendor booths on the expo floor at the 2017 meeting of the American College of Cardiology (ACC). For key technology trends at ACC.17, watch the VIDEO "Cardiac Technology Trends at ACC.17."

VIDEO: Editor's Choice of Most Innovative New Technology at ACC.17
/videos/video-bioresorbable-stent-comparable-xience-two-years-concerns
Stents Bioresorbable | March 30, 2017
VIDEO: Bioresorbable Stent Comparable to Xience at Two Years, With Concerns

Stephen Ellis, M.D., professor of medicine and director of interventional cardiology at Cleveland Clinic, discusses the two year outcomes of the ABSORB III trial of Absorb vs. Xience. The late-breaking trial was presented at ACC 2017. Read the article on the ABSORB III results.  Watch a VIDEO with Gregg Stone, M.D., "Poor Outcomes for Bioresorbable Stents in Small Coronary Arteries."

VIDEO: Bioresorbable Stent Comparable to Xience at Two Years, With Concerns
/videos/video-cardiac-technology-trends-acc17
Cath Lab | March 28, 2017
VIDEO: Cardiac Technology Trends at ACC.17

MDBuyline analyst Tom Watson shares some of the most important trends in cardiac technology he saw at the 2017 American College of Cardiology (ACC) Scientific Sessions. For a list of late-breaking trials and links to related articles read "ACC 2017 Late-Breaking Trials." Watch a VIDEO of Watson's assessment of trends at ACC.16.

VIDEO: Cardiac Technology Trends at ACC.17
/videos/video-tavr-stands-equal-surgical-valve-replacement
Heart Valve Technology | March 24, 2017
VIDEO: TAVR Stands Equal to Surgical Valve Replacement

Michael Reardon, M.D., professor of cardiothoracic surgery at Houston Methodist DeBakey Heart and Vascular Center, discusses the positive results of the SURTAVI trial that were presented at ACC.17. Reardon was the principal investigator for the SURTAVI trial. Read the article "TAVR Stands Equal to Surgical Valve Replacement." 

VIDEO: TAVR Stands Equal to Surgical Valve Replacement
/videos/video-ifr-equal-ffr-outcomes-coronary-lesion-evaluation
FFR Technologies | March 23, 2017
VIDEO: iFR Equal to FFR Outcomes in Coronary Lesion Evaluation

Justin Davies, MBBS, of Imperial College London, and Matthias Götberg, M.D, Ph.D., of Skane University Hospital, detail the positive results of the DEFINE-FLAIR and IFR-SWEDEHEART trials presented at ACC.17. Read the article “Easier to Use iFR Equal to Outcomes of FFR in Coronary Lesion Evaluation.”

VIDEO: iFR Equal to FFR Outcomes in Coronary Lesion Evaluation
/videos/video-demonstration-impella-percutaneous-hemodynamic-support-device
Hemodynamic Support Devices | March 21, 2017
VIDEO: Demonstration of the Impella Percutaneous Hemodynamic Support Device

This video, provided by Abiomed, demonstrates the Impella percutaneous ventricular assist devices (pVAD). It offers between 2.5 and 5 liters of flow per minute to help off load the heart and aid organ perfusion in patients with significantly compromised cardiac output. The Impella has an FDA indication for cardiogenic shock and is the key device being used in the Detroit Cardiogenic Shock Initiative, which was launched in 2017. Read the article "Collaboration by Metro Detroit Cardiologists Increases Cardiogenic Shock Survival Rate."

VIDEO: Demonstration of the Impella Percutaneous Hemodynamic Support Device
/videos/video-minneapolis-heart-institute-saves-analytics-software
Analytics Software | March 15, 2017
VIDEO: Minneapolis Heart Institute Saves With Analytics Software

Pam Rush, RN, MS, clinical program director, cardiovascular service line, and Craig Strauss, M.D., MPH, medical director, explain how MHI achieved significant savings by leveraging analytics software for reductions in patient complications, better vendor negotiations and other areas. Read the article “Advanced Analytics Software for Cardiology.”
 

VIDEO: Minneapolis Heart Institute Saves With Analytics Software
/videos/editors-choice-most-innovative-technology-himss-2017
HIMSS | March 10, 2017
Editor's Choice of Most Innovative Technology at HIMSS 2017

ITN Editor Dave Fornell takes a tour of some of the most innovative new technology that was displayed on the expo floor at the 2017 Healthcare Information and Management Systems Society (HIMSS) annual meeting. The two most significant technology advances are discussed in Fornell's blog "Two Technologies That Offer a Paradigm Shift in Medicine at HIMSS 2017."

Editor's Choice of Most Innovative Technology at HIMSS 2017
Overlay Init